Skip to main content

Table 8 Results from dose plan analysis for Patient 4

From: On the performances of different IMRT treatment planning systems for selected paediatric cases

 

Obj

Corvus1

Eclipse1

Hyperion2

KonRad1

OMP2

PinnEUD2

PinnPhy2

Precise2

PTV1 (18 Gy)

Maxpt Gy

Prescript

21.0

20.0

21.4

22.5

21.7

23.9

21.0

23.6

D1% Gy

Prescript

20.0

19.5

20.4

21.6

19.8

21.7

19.6

21.4

D99% Gy

Prescript

15.2

14.2

11.8

12.9

16.2

14.5

16.2

14.3

V90% %

100%

96.8

96.7

91.9

95.2

99.0

97.4

99.0

97.6

V107% %

0%

7.3

2.4

14.6

18.5

3.8

13.8

2.2

12.7

SD Gy

0 Gy

0.9

0.9

1.5

1.5

0.7

1.2

0.6

1.2

CI

1.0

1.53

1.12

1.11

1.30

1.28

1.16

1.27

1.31

Kidney

Mean Gy

< 10 Gy

7.7

5.1

6.4

8.0

9.3

7.7

9.7

9.3

Max pt Gy

Minimise

17.5

13.4

12.2

13.4

18.1

13.7

17.3

14.1

D1% Gy

Minimise

14.8

12.0

11.3

12.5

16.7

12.7

16.0

13.4

V5 Gy %

Minimise

78.6

39.7

72.2

97.2

98.0

87.8

97.3

98.1

Healthy tissue

Mean Gy

Minimise

8.8

6.1

7.0

7.9

8.2

7.1

7.6

7.0

Max pt Gy

Minimise

20.5

19.7

17.7

22.6

21.6

20.6

20.6

23.1

V10 Gy cm3

Minimise

1920

970

1200

1580

1650

1380

1600

1300

nV10 Gy

Minimise

1.9

0.8

0.9

1.3

1.4

1.1

1.3

1.1

V90% cm3

Minimise

561

206

219

440

339

227

331

348

  1. 1: TPS belonging to the first family type
  2. 2: TPS belonging to the second family type